# Biodock

**Source:** https://geo.sig.ai/brands/biodock  
**Vertical:** Healthcare  
**Subcategory:** General  
**Tier:** Emerging  
**Website:** biodock.ai  
**Last Updated:** 2026-04-14

## Summary

AI cloud computing platform for life sciences microscopy images and NGS sequencing data management; $2.1M a16z pre-seed backed YC W21 at $750K ARR serving biotech and academic research labs.

## Company Overview

Biodock is a San Francisco-based AI cloud computing platform for life sciences research — providing data management, analysis, and collaboration infrastructure specifically designed for biological research data including microscopy images, next-generation sequencing (NGS) outputs, and other large-scale biological datasets that overwhelm general-purpose cloud storage and analytics tools. Founded in 2020 and backed by Andreessen Horowitz in a pre-seed round with $2.1-2.33 million raised, plus notable angel investors from Tiger Global and Flatiron Health, Biodock (YC W21) reached $750,000 in annual revenue as of June 2025.

Biodock's biological data platform addresses the storage, sharing, and analysis challenges specific to life sciences research: microscopy images from confocal or electron microscopes generate terabytes per experiment; NGS sequencing files require bioinformatics pipelines to interpret; and research teams at universities and biotech companies need to share these large, complex datasets with collaborators while maintaining data security. Biodock provides the storage, annotation, and analysis infrastructure that replaces the ad hoc combination of Dropbox, S3 buckets, and local NAS drives most research labs use.

In 2025, Biodock competes in the life sciences research data management and bioinformatics cloud market with Benchling (the dominant lab informatics platform, $1.1B valuation), Labviva (lab procurement), Flywheel (medical imaging and research data management), and cloud storage platforms (AWS, Google Cloud) for research laboratory data infrastructure. The life sciences research data market has grown as sequencing costs have dropped and microscopy techniques have advanced — the data generated per experiment has grown orders of magnitude faster than research lab IT infrastructure capacity. a16z's investment in Biodock (even at pre-seed stage) reflects conviction in the research data infrastructure opportunity. The 2025 strategy focuses on growing university research lab and biotech company customers, deepening the image analysis AI for specific microscopy modalities, and building the collaboration features that connect geographically distributed research teams.

## Frequently Asked Questions

### What is Biodock?
Biodock is a San Francisco-based biotech company founded in 2020 that provides AI cloud computing for biological research data. The company specializes in analyzing microscopy images, NGS sequencing data, and other biological research data for life sciences researchers.

### What products and services does Biodock offer?
Biodock offers AI cloud computing solutions including microscopy image analysis, NGS sequencing data analysis, and a biological research platform. Their services are designed specifically for life sciences AI applications.

### Who are Biodock's target customers?
Biodock serves life sciences researchers who work with microscopy images, NGS sequencing data, and other biological research data. Their platform is designed for professionals in the biotech and life sciences research fields.

### When was Biodock founded?
Biodock was founded in 2020 and was part of Y Combinator's Winter 2021 (W21) cohort.

### Where is Biodock located?
Biodock is headquartered in San Francisco, California, United States. The company has 7 employees distributed across North America and Asia.

### How much funding has Biodock raised?
Biodock raised between $2.1M and $2.33M in a pre-seed round in March 2021. The round was led by Andreessen Horowitz with participation from TQ Ventures, Soma Capital, and notable angels including John Curtius from Tiger Global and Zach Weinberg, co-founder of Flatiron Health.

### What is Biodock's current revenue?
As of June 2025, Biodock reached $750K in annual revenue. The company has grown to 7 employees across North America and Asia.

### What technology does Biodock use?
Biodock uses artificial intelligence (AI) and cloud computing technology to analyze biological research data. Their platform specializes in processing microscopy images and NGS sequencing data for life sciences applications.

### Is Biodock part of Y Combinator?
Yes, Biodock was part of Y Combinator's Winter 2021 (W21) cohort. This accelerator program helped support the company's early development.

### What are Biodock's recent developments?
Biodock completed a pre-seed funding round of $2.1M-$2.33M in March 2021 led by Andreessen Horowitz. As of June 2025, the company has grown to 7 employees and achieved $750K in annual revenue.

## Tags

healthtech, saas, global, b2b

---
*Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*